Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Side effect profile by dose Gastrointestinal side effects were the most common adverse events and were clearly dose-related
Clinical trials have shown significant weight loss (up to 24%) and improvements in glycemic control, liver fat, and insulin sensitivity, offering a comprehensive approach to obesity and type 2 diabetes management
Ipamorelin is described in the literature as the most selective growth hormone secretagogue receptor agonist among synthetic GHRPs
FDA Drug Bulletin
US$ 23.32
US$ 28.77
US$ 21.70
US$ 23.78
US$ 22.33
